Allspring Global Investments Holdings LLC Purchases 25,098 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Allspring Global Investments Holdings LLC raised its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 226.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,161 shares of the company’s stock after acquiring an additional 25,098 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Pediatrix Medical Group were worth $336,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Pacer Advisors Inc. lifted its holdings in shares of Pediatrix Medical Group by 126.9% in the fourth quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after acquiring an additional 1,809,828 shares during the last quarter. Moody National Bank Trust Division raised its holdings in Pediatrix Medical Group by 23.4% in the 4th quarter. Moody National Bank Trust Division now owns 41,573 shares of the company’s stock valued at $387,000 after buying an additional 7,871 shares during the last quarter. Exchange Traded Concepts LLC raised its holdings in Pediatrix Medical Group by 43.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 43,368 shares of the company’s stock valued at $403,000 after buying an additional 13,194 shares during the last quarter. AXQ Capital LP bought a new position in Pediatrix Medical Group in the 3rd quarter valued at approximately $135,000. Finally, AQR Capital Management LLC raised its holdings in Pediatrix Medical Group by 43.7% in the 3rd quarter. AQR Capital Management LLC now owns 559,879 shares of the company’s stock valued at $7,116,000 after buying an additional 170,375 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on MD. Truist Financial dropped their price objective on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a report on Wednesday, February 21st. TheStreet lowered shares of Pediatrix Medical Group from a “c” rating to a “d” rating in a report on Friday, February 23rd. Jefferies Financial Group dropped their price objective on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, March 6th. Finally, Mizuho decreased their target price on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. Five analysts have rated the stock with a hold rating, Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus target price of $10.30.

Pediatrix Medical Group Trading Up 1.6 %

NYSE MD opened at $9.05 on Friday. The stock has a market capitalization of $760.05 million, a price-to-earnings ratio of -12.38, a PEG ratio of 2.50 and a beta of 1.58. Pediatrix Medical Group, Inc. has a one year low of $7.70 and a one year high of $15.06. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24. The business’s fifty day moving average is $9.20 and its 200-day moving average is $9.63.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, February 20th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. The company had revenue of $496.44 million for the quarter, compared to analysts’ expectations of $524.30 million. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. The business’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 EPS. Equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.12 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.